Hosted on MSN
Patient-centric trials: progress but gaps remain
Patient-centricity has become a buzzword in recent years, with companies touting more inclusive trial designs and bringing patients and advocates into early planning stages. On Clinical Trials Day ...
Cancer clinical trials represent a critical mechanism to advance the fields of hematology and oncology. Every US Food and Drug Administration (FDA)-approved cancer treatment has made its way through ...
The progress the UK has made as a global contributor to clinical trials is “remarkable”, says Lord James O’Shaughnessy, former health minister and author of the landmark report into the domestic ...
Perspective Therapeutics Inc. (NYSE:CATX) is one of the best high-return penny stocks to buy right now. On February 2, ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Please provide your email address to receive an email when new articles are posted on . Women are historically underrepresented in cardiovascular trials. Recent trials on acute coronary syndrome, ...
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer's disease in closely watched trials, Novo Nordisk said Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results